Fortrea Holdings (FTRE) Receivables - Net (2022 - 2026)
Fortrea Holdings (FTRE) posted Receivables - Net of $619.6 million for Q1 2026, up 5.07% on a QoQ basis from $589.7 million in Q4 2025, and down 15.01% year-over-year from $729.0 million in Q1 2025.
Fortrea Holdings (FTRE) Receivables - Net (2022 - 2026) Analysis & Trends
Fortrea Holdings' Receivables - Net history runs 5 years deep, the most recent figure standing at $619.6 million for Q1 2026.
- Quarterly Receivables - Net fell 15.01% year-over-year to $619.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $619.6 million (down 15.01% YoY) and the FY2025 annual result came in at $589.7 million, down 10.58% from the prior year.
- Receivables - Net was $619.6 million for Q1 2026 at Fortrea Holdings, up from $589.7 million in the prior quarter.
- Across five years, Receivables - Net topped out at $1.0 billion in Q3 2023 and bottomed at $420.2 million in Q4 2023.
- A 5-year average of $751.7 million and a median of $689.1 million in 2024 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2023 — Receivables - Net sank 58.89% — and 2024, when it jumped 56.95%.
- Fortrea Holdings' Receivables - Net stood at $1.0 billion in 2022, then sank by 58.89% to $420.2 million in 2023, then soared by 56.95% to $659.5 million in 2024, then slipped by 10.58% to $589.7 million in 2025, then grew by 5.07% to $619.6 million in 2026.
- Business Quant data shows FTRE's Receivables - Net at $619.6 million in Q1 2026, $589.7 million in Q4 2025, and $663.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 619.60 Mn |
| Mar 31, 2026 | 619.60 Mn |
| Dec 31, 2025 | 589.70 Mn |
| Dec 31, 2025 | 589.70 Mn |
| Sep 30, 2025 | 663.20 Mn |
| Sep 30, 2025 | 663.20 Mn |
| Jun 30, 2025 | 739.20 Mn |
| Jun 30, 2025 | 739.20 Mn |
| Mar 31, 2025 | 729.00 Mn |
| Mar 31, 2025 | 729.00 Mn |
| Dec 31, 2024 | 659.50 Mn |
| Dec 31, 2024 | 659.50 Mn |
| Sep 30, 2024 | 689.10 Mn |
| Sep 30, 2024 | 689.10 Mn |
| Jun 30, 2024 | 637.90 Mn |
| Jun 30, 2024 | 637.90 Mn |
| Mar 31, 2024 | 941.00 Mn |
| Mar 31, 2024 | 941.00 Mn |
| Dec 31, 2023 | 420.20 Mn |
| Dec 31, 2023 | 420.20 Mn |